Operating Lease, Right-of-Use Asset of PMV Pharmaceuticals, Inc. from 31 Mar 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
PMV Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2021 to 30 Sep 2025.
  • PMV Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $891,000, a 89% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

PMV Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $891,000 -$7,516,000 -89% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $977,000 -$7,061,000 -88% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $1,061,000 -$7,150,000 -87% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $1,143,000 -$7,239,000 -86% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $8,407,000 -$138,000 -1.6% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $8,038,000 -$691,000 -7.9% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $8,211,000 -$919,000 -10% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $8,382,000 -$1,157,000 -12% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $8,545,000 -$990,000 -10% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $8,729,000 -$941,000 -9.7% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $9,130,000 -$606,000 -6.2% 31 Mar 2023 10-Q 10 May 2023 2023 Q3
Q4 2022 $9,539,000 -$521,000 -5.2% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $9,535,000 -$875,000 -8.4% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $9,670,000 -$1,093,000 -10% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $9,736,000 +$8,908,000 +1076% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $10,060,000 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $10,410,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $10,763,000 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 $828,000 31 Mar 2021 10-Q 14 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.